Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
For adults 80 and older with type 2 diabetes, aggressively lowering blood sugar doesn't reduce the risk of heart or kidney complications — but it does significantly raise the risk of dangerous low blood sugar episodes. A new randomized trial suggests that in this age group, quality of life and safety should take priority over hitting strict glucose targets. The takeaway: less may truly be more for older diabetic patients.
For decades, tight blood sugar control has been a cornerstone of type 2 diabetes (T2D) management. But a new randomized trial published in Diabetes Research and Clinical Practice challenges whether that approach makes sense for the very old — and the findings are striking.
Researchers followed 206 adults aged 80 and older with T2D for five years, randomly assigning them to either intensive or conservative glycemic therapy. While the intensive group achieved meaningfully lower HbA1c levels, that didn't translate into fewer vascular complications — microvascular or macrovascular. What it did produce was a dramatically higher rate of severe hypoglycemia hospitalizations.
Notably, death was the most common outcome overall, occurring in nearly one-third of participants, underscoring how competing health risks in this age group can overshadow any potential long-term glycemic benefit.
By the Numbers
Why it matters: As the global population ages, more clinicians are managing T2D in octogenarians. This trial sends a clear signal: for patients 80 and older, treatment goals should shift toward safety, avoiding hypoglycemia, and preserving independence — not chasing tight glucose numbers.
